DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 40 filers reported holding DECIBEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,139,685 | $12,087,787 | 66.30% |
| Samsara BioCapital, LLC | 801,629 | $3,086,272 | 0.54% |
| Orbimed Advisors | 4,945,192 | $19,038,989 | 0.34% |
| Alphabet Inc. | 1,636,258 | $6,299,593 | 0.34% |
| Newtyn Management, LLC | 200,000 | $770,000 | 0.18% |
| HARVARD MANAGEMENT CO INC | 326,029 | $1,255 | 0.12% |
| Acuitas Investments, LLC | 41,960 | $161,546 | 0.09% |
| Bronte Capital Management Pty Ltd. | 154,878 | $596,280 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 199,200 | $766,920 | 0.02% |
| ATLAS CAPITAL ADVISORS LLC | 25,000 | $96,250 | 0.02% |